| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
4d Molecular Therapeutics, Inc. (FDMT) has 6 insiders with recent SEC Form 4 filings, including 4 buys and 13 sells. FDMT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 1.06M | $10.21M | -1,922 | |
| CFO | 480.0K | $4.64M | - | |
| VP | 47.2K | $456.2K | - | |
| Dir | 45.0K | $434.7K | - | |
| Other | 3.6K | $34.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 22, 2021 | Schaffer David86 | Director | Sell | 36,285 | $31.36 | $1,137,819.21 | -1.3% | -53.9% | -78.9% | |
| Sep 30, 2021 | Schaffer David86 | Director | Sell | 29,256 | $27.89 | $815,863.26 | -0.6% | -21.6% | -70.2% | |
| Sep 28, 2021 | Schaffer David86 | Director | Sell | 33,244 | $31.90 | $1,060,518.15 | -0.7% | -28.2% | -70.5% | |
| Dec 15, 2020 | Viking Global Investors LP66 | 10% Owner | Buy | 1,100,000 | $23.00 | $25,300,000.00 | +38.8% | - | - | |
| Dec 15, 2020 | Yao Tony Dung Ling | Director | Buy | 425,000 | $23.00 | $9,775,000.00 | +66.8% | - | - | |
| Dec 15, 2020 | Kamal Fariborz | See Remarks | Buy | 4,347 | $23.00 | $99,981.00 | New | - | - | |
| Dec 15, 2020 | Milligan John F | Director | Buy | 100,000 | $23.00 | $2,300,000.00 | New | - | - |